RAC 2.20% $1.78 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-72

  1. 93 Posts.
    lightbulb Created with Sketch. 84
    Yes, it's not hard to lose sight of what is important. These numbers on a page represent real people, with real lives being given a second chance at life. What price can you put on that. It appears that Bis will give hope to many patients and that is an incredible thing to be a part of. It's now up to management to get Bis into the clinic to prove out the CP/FTO so more patients can be treated and given this life changing drug. The profits will follow. GLTAH / IMO.

    Edit: Forgot to mention, great work @Davisite on the announcement, well written as usual and the Q&A's are exceptional. Looking forward to future announcements.
    Last edited by Kookie7: 07/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.